A synthetic peptide for use as a blocking control in assays to test for specificity of MGAT2 antibody, Alternative Names: MGAT2 control peptide, MGAT2 antibody Blocking Peptide, Anti-MGAT2 Blocking Peptide, Mannosyl Blocking Peptide, Alpha 1-6-Glycoprotein Beta-1-2-N-Acetylglucosaminyltransferase Blocking Peptide, CDGS2 Blocking Peptide, GLCNACTII Blocking Peptide, GNT-II Blocking Peptide, GNT2 Blocking Peptide, MGAT2, MGAT-2, MGAT 2, MGAT-2 Blocking Peptide, MGAT 2 Blocking Peptide
Aufreinigung
The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
MGAT2 is a Golgi enzyme catalyzing an essential step in the conversion of oligomannose to complex N-glycans. The enzyme has the typical glycosyltransferase domains: a short N-terminal cytoplasmic domain, a hydrophobic non-cleavable signal-anchor domain, and a C-terminal catalytic domain. Mutations in its gene may lead to carbohydrate-deficient glycoprotein syndrome, type II. The product of this gene is a Golgi enzyme catalyzing an essential step in the conversion of oligomannose to complex N-glycans.